AI steps in: new tool aims to predict who wins against liver cancer
NCT ID NCT07495735
Summary
This study aims to create an artificial intelligence (AI) tool that can predict how well patients with advanced liver cancer will respond to a specific combination of two drugs. Researchers will look back at the medical records and CT scans of 400 patients who have already received this treatment. The goal is to build a non-invasive model that helps doctors identify, before starting treatment, which patients are most likely to benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.